1. Home
  2. OLMA vs NIU Comparison

OLMA vs NIU Comparison

Compare OLMA & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NIU
  • Stock Information
  • Founded
  • OLMA 2006
  • NIU 2014
  • Country
  • OLMA United States
  • NIU China
  • Employees
  • OLMA N/A
  • NIU N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NIU Auto Manufacturing
  • Sector
  • OLMA Health Care
  • NIU Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • NIU Nasdaq
  • Market Cap
  • OLMA 299.7M
  • NIU 275.6M
  • IPO Year
  • OLMA 2020
  • NIU 2018
  • Fundamental
  • Price
  • OLMA $5.33
  • NIU $3.51
  • Analyst Decision
  • OLMA Strong Buy
  • NIU
  • Analyst Count
  • OLMA 4
  • NIU 0
  • Target Price
  • OLMA $24.50
  • NIU N/A
  • AVG Volume (30 Days)
  • OLMA 411.5K
  • NIU 604.1K
  • Earning Date
  • OLMA 08-05-2025
  • NIU 08-11-2025
  • Dividend Yield
  • OLMA N/A
  • NIU N/A
  • EPS Growth
  • OLMA N/A
  • NIU N/A
  • EPS
  • OLMA N/A
  • NIU N/A
  • Revenue
  • OLMA N/A
  • NIU $477,578,753.00
  • Revenue This Year
  • OLMA N/A
  • NIU $41.32
  • Revenue Next Year
  • OLMA N/A
  • NIU $24.38
  • P/E Ratio
  • OLMA N/A
  • NIU N/A
  • Revenue Growth
  • OLMA N/A
  • NIU 26.51
  • 52 Week Low
  • OLMA $2.86
  • NIU $1.66
  • 52 Week High
  • OLMA $16.62
  • NIU $4.90
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.85
  • NIU 47.34
  • Support Level
  • OLMA $4.40
  • NIU $3.58
  • Resistance Level
  • OLMA $5.36
  • NIU $3.65
  • Average True Range (ATR)
  • OLMA 0.29
  • NIU 0.18
  • MACD
  • OLMA 0.07
  • NIU -0.01
  • Stochastic Oscillator
  • OLMA 93.20
  • NIU 25.61

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NIU Niu Technologies

Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

Share on Social Networks: